Connect with us

Technology

Respected pharma data science pioneer Dr Ben Sidders to spearhead Biorelate’s next growth phase as Chief Scientific Officer

Published

4 months ago

on

* Dr Sidders brings two decades of deep data science experience, honed across multiple therapeutic areas at Pfizer and AstraZeneca * He will build on Biorelate’s strong track record of leveraging advanced data science methods to extract critical knowledge from vast amounts of biomedical literature * These new data-derived insights are enabling drug developers to identify new targets with maximum market potential.

MANCHESTER, England, Sept. 5, 2024 /PRNewswire-PRWeb/ — Biorelate has announced the appointment of leading pharmaceutical industry data science expert, Dr Ben Sidders, as Chief Scientific Officer. Formerly Executive Director, Head of Early Data Science at AstraZeneca within Oncology R&D, Dr Sidders will spearhead a new growth phase for Biorelate, which leverages advanced data science methods to transform the focus and impact of drug discovery and development.

This prestigious appointment is an important endorsement of the great work we are doing, and we are delighted to welcome Ben on board. His scientific direction will give Biorelate an even deeper footing within modern drug discovery and development.

Dr Sidders has spent two decades leading data science teams at both AstraZeneca and Pfizer, to pioneer and apply novel data science methods for drug discovery in oncology, neuroscience and infectious disease.

Biorelate specialises in advanced data science methods for drug discovery to deliver robust, evidence-based intelligence to those making critical decisions about the next drugs to take forward. The actionable insights it distils, from across diverse ‘dark’ (previously unsearchable) knowledge assets and existing texts, ensure that investment is concentrated on the targets most likely to succeed in drug development – with a positive impact for patients, while delivering financially for the drug developer and its backers.

Dr Sidders, who has followed Biorelate closely since the company’s foundation in 2014, believes the company is at an important inflection point thanks to its proven technology and a significant opportunity to grow and scale. That’s as drug developers look to next-generation data science to transform their early research, and improve new drug candidates’ probability of success.

Of the opportunity Biorelate addresses, Dr Sidders said: “The pharmaceutical industry is rapidly adopting data science-driven approaches using artificial intelligence. This has meant a shift away from the traditional pharma R&D model (very low throughput, with heavy reliance on academic literature to determine new targets), towards an Artificial Intelligence (AI)-first approach.

“The risk with this approach is that researchers do not really understand the causality of their findings, which is critical if you want to develop a successful drug. Biorelate fills that gap by drawing on a wealth of data to develop causal models and explaining – mechanistically and in the appropriate context – what the next opportunities are and why. Crucially, Biorelate’s technology platform has causality built in – something that’s lacking in other AI approaches to drug discovery. It has proven adept at finding new targets, and has promise in other areas of the pipeline too, from biomarker discovery and patient stratification to the identification of promising drug combinations. This is a really exciting time for Biorelate, and for data science in drug discovery more broadly.”

Daniel Jamieson, Biorelate’s CEO, said: “This prestigious appointment is an important endorsement of the great work we are doing, and we are delighted to welcome Ben on board. His scientific direction will give Biorelate an even deeper footing within modern drug discovery and development.

“At AstraZeneca, Ben’s team was responsible for delivering data-driven, actionable insights to all parts of the company’s oncology portfolio, including advancing the understanding of disease. His years at Pfizer, and his extensive experience of all facets of drug discovery across major pharma, add richly to his understanding of what the industry needs now to transform R&D performance – insights and expertise we can now extend to our diverse client base.”

Dr Sidders’ personal fields of interest include immuno-oncology, network biology and the role of bioinformatics within drug discovery. He has a PhD in Molecular Biology & Bioinformatics from the University of London where his thesis focused on the development of predictive markers for the diagnosis of asymptomatic Tuberculosis. Ben holds patents for two clinical diagnostics and has authored over 30 scientific publications.

About Biorelate

Biorelate is a world leader in leveraging advanced data science methods to extract critical knowledge from vast amounts of pharmaceutical data and literature, significantly enhancing the discovery of novel biopharmaceuticals. Biorelate offers multiple product lines powered by its proprietary platform, Galactic AI™.

Galactic AI™ employs sophisticated natural language processing (NLP) and artificial intelligence (AI) to uncover hidden cause- and-effect relationships. This innovative platform provides unprecedented insights into disease pathways, enabling more precise and effective drug discovery. As the incredible progress of scientific researchers continues to compound the huge volume of growing and evolving biomedical data, Biorelate’s mission to curate knowledge to advance the world’s most promising biomedical innovations has never been so important.

Media Contact

Mira Nair, Biorelate, 44 07799153550, mira.nair@biorelate.com, https://biorelate.com/

View original content to download multimedia:https://www.prweb.com/releases/respected-pharma-data-science-pioneer-dr-ben-sidders-to-spearhead-biorelates-next-growth-phase-as-chief-scientific-officer-302239087.html

SOURCE Biorelate

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Thinkpal learning tablet from Think Academy wins TechRadar Pro Picks and Trusted Reviews Best in Show awards at CES 2025

Published

21 minutes ago

on

January 11, 2025

By

LAS VEGAS, Jan. 11, 2025 /PRNewswire/ — Think Academy debuted its Thinkpal tablet at CES 2025 and has won a TechRadar Pro Picks and Trusted Reviews Best in Show awards for this innovative new product.

Both awards are given to innovative products and solutions at CES that stand out from a packed crowd. Think Academy President, Alex Peng, was presented the awards at CES, noting the awards were given to Thinkpal because it is both a wholly unique product in the education technology market and also provides such value to parents and educators.

Designed to transform the way kids learn, explore, and thrive in an ever-evolving world, the Thinkpal is powered by cutting-edge AI that serves as a guide and tutor for young learners. With significant learning loss experienced in recent years, families and educators have faced unprecedented challenges as test scores in reading and math have seen steady declines. Parents have expressed their struggles in reigniting their children’s passion for learning, while educators grapple with the complexities of bridging diverse learning gaps.

To meet these challenges, the Thinkpal tablet offers a tailored, AI-powered solution that provides step-by-step writing guidance and real-time math support, making learning more intuitive and enjoyable.

Alex Peng introduced several key features of the Thinkpal during a press event. He showed the audience how Thinkpal’s “GeniusTutor,” an AI-powered system that transforms learning into an interactive and engaging experience, is the heart of this product’s features. Built on the Microsoft Azure OpenAI GPT-4o model, GeniusTutor provides real-time guidance and feedback, empowering students to:

Conquer complex math problems through logic-driven, step-by-step explanationsMaster writing with interactive prompts and instant feedback that build confidence and creativityEnhance vocabulary and reading skills with innovative tools like “Point-and-Discover,” where children can point to words in a physical book, and the tablet’s camera instantly provides explanations, along with guided reading exercises

Adding a touch of fun and companionship, “Thinkie,” an advanced AI-powered learning companion, engages children through voice-based natural language interactions. Thinkie chats, answers questions, and fosters curiosity, making the learning process enjoyable and dynamic.

With an extensive library of ebooks, gamified coursework, and compatibility with popular applications like Google Classroom, the Thinkpal Tablet is a versatile tool for modern families. The 11-inch TÜV Rheinland-certified eye-care screen also safeguards children’s vision during extended use, while the optional keyboard transforms the tablet into a Chromebook-like device, enhancing productivity and usability.

“Our mission is to provide every child with a personalized, world-class tutor that inspires confidence and a lifelong love for learning”, noted Alex Peng during a media interview Q&A. “We’re honored that TechRadar and Trusted Reviews recognize the potential of the Thinkpal to improve learning through advanced and accessible technology.”

The Thinkpal Tablet will be available for $249 ($339 including keyboard) at shop.thethinkacademy.com. Pre-orders open today.

About Think Academy

Think Academy, a subsidiary of TAL Education Group (NYSE: TAL), has been at the forefront of education innovation for over two decades. Serving more than 5 million K-12 students across 10+ countries, Think Academy is dedicated to creating fair and comprehensive educational opportunities. By integrating advanced technology with expert curriculum design, Think Academy is shaping the future of learning to be more accessible, engaging, and impactful.

For media inquiries, contact:
Cecilia Qian
cecilia@impact5r.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinkpal-learning-tablet-from-think-academy-wins-techradar-pro-picks-and-trusted-reviews-best-in-show-awards-at-ces-2025-302348472.html

SOURCE Think Academy

Continue Reading

Technology

MLVision M5 Unveiled at CES 2025: Pioneering Innovation in Wearable Technology with the World’s Lightest AI-Powered AR Glasses

Published

21 minutes ago

on

January 11, 2025

By

LAS VEGAS, Jan. 11, 2025 /PRNewswire/ — At CES 2025, MLVision has officially launched its groundbreaking MLVision M5, setting a new global standard for wearable technology. Weighing a mere 25.8 grams, the MLVision M5 is the world’s lightest AI-powered AR glasses. The device combines cutting-edge artificial intelligence, precision engineering, and a commitment to privacy and accessibility.

“MLVision M5 is more than just a wearable device; it represents a significant breakthrough in both weight and product design,” said CEO Zhaoen Dai. “Our goal is to create smart AR glasses that feel effortless to wear, leveraging cutting-edge AR display technology and advanced AI models to genuinely help users work and live more efficiently and conveniently.”

Crafted with aviation-grade titanium and ultra-lightweight floating plastic, this device achieves an unprecedented balance between durability and comfort. Weighing only 25.8g, 40% less than traditional AR glasses, it ensures an effortless, all-day wearing experience that feels almost weightless. The ergonomic design caters to users’ needs, making it a perfect companion for both work and leisure.

This device introduces an industry-first modular design, setting a new benchmark for adaptability in AR glasses. This innovation allows users to seamlessly transition between an all-in-one configuration and a clip-on style, accommodating diverse preferences and use cases. For nearsighted users, the M5 eliminates the need for custom prescription lenses—a common limitation in traditional AR glasses. Instead, it can be conveniently clipped onto existing prescription glasses, offering unmatched practicality and cost savings. This thoughtful modularity not only enhances accessibility but also positions the MLVision M5 as a versatile solution for a broad spectrum of users.

One of MLVision M5’s standout features is its immersive visual projection system, which offers an 86-inch private virtual screen. Powered by MLVision’s proprietary Hummingbird Micro-LED light engine and advanced nano-scale diffraction waveguide technology, the glasses create a secure and private viewing experience, ideal for reading confidential documents or browsing personal files. To prioritize eye health, the device utilizes soft green light with a projection distance of 4 meters, reducing strain during extended use.

The MLVision M5 is also equipped with the AIOS platform, delivering unparalleled AI-driven capabilities to enhance user productivity and accessibility. With intelligent tools like document summarization, real-time translation in seven languages, and interactive AI chat for setting reminders and brainstorming ideas, the device seamlessly integrates into the modern workflow. Additionally, its innovative Care Mode provides real-time audio transcription, enabling a more inclusive experience for users with hearing impairments.

The MLVision M5 excels as a navigation powerhouse, offering intuitive, real-time directions to guide users seamlessly through various environments. Whether exploring a new city, finding the fastest route to your destination, or navigating while riding a bike, the M5 ensures you always stay on the right path with ease and confidence.

The MLVision M5 will launch in China at the end of January 2025. Pricing and pre-order details will be announced in the coming weeks.

MLVision, a global innovator in wearable technology, continues to push the boundaries of what is possible by merging innovation, style, and functionality. With the launch of MLVision M5, the company reinforces its commitment to accessibility, sustainability, and creating cutting-edge solutions that redefine how technology is integrated into everyday life.

View original content to download multimedia:https://www.prnewswire.com/news-releases/mlvision-m5-unveiled-at-ces-2025-pioneering-innovation-in-wearable-technology-with-the-worlds-lightest-ai-powered-ar-glasses-302348534.html

SOURCE MLVision

Continue Reading

Technology

Brandivio Launches Advanced Retail Allocation Platform for Inventory Excellence

Published

21 minutes ago

on

January 11, 2025

By

Brandivio’s inventory optimization solutions empower footwear and apparel brands and retailers to buy smarter, allocate & replenish faster, and meet demand with precision.

NEW YORK, Jan. 11, 2025 /PRNewswire-PRWeb/ — Brandivio, a new generation inventory excellence platform for apparel and footwear retailers, announces its expansion into North America, in conjunction with the National Retail Federation’s (NRF) Big Show in New York City.

The Brandivio platform addresses the unique needs of the retail allocation market, ensuring apparel and footwear retailers have innovative tools to grow and thrive,” said Keith Whaley, SVP of Retail Solutions at Brandivio.

Brandivio, already supporting top-tier brands in EMEA, is built by seasoned retail experts to solve critical inventory challenges in fashion and footwear.

Leveraging machine learning, real-time demand signals, and automation, the Brandivio platform optimizes the distribution of products across a retailer’s stores and e-commerce channels ensuring the right products are in the right places at the right times, ultimately improving sales and margin performance, customer satisfaction, and inventory efficiency.

Key Features of Brandivio –

Advanced Demand Sensing: Predict future demand for short lifecycle products using machine learning native algorithms incorporating hyper-local external datasets to map powerful demand drivers.Dynamic Inventory Allocation: Adjust inventory in real time at the SKU/location level based on in-season trends to reduce stockouts and overstock situations.Real-Time Analytics: Drive test and learn strategies, optimize assortment in-season and connect functional teams across the organization with actionable insights for rapid response to market trends.Automation: Reduce up to 80% of existing manual planning efforts and redirect planner focus towards even greater efficiencies.Ease of Use: Intuitive workflows ensure rapid adoption without extensive training.

“Retailers can no longer rely on outdated tools or seasonal strategies,” said James Townsend, CEO of Brandivio.

“Brandivio democratizes retail data science, enabling brands to level the playing field, compete effectively, and maximize profits in today’s fast-paced market.”

This launch underscores Brandivio’s mission to support U.S. retailers facing tighter margins and increasing competition. “Our platform addresses the unique needs of this market, ensuring retailers have the tools to grow and thrive,” added Keith Whaley, SVP of Retail Solutions.

Contact us for a demo at info@brandivio.com or visit Brandivio.com for more.

Media Contact

Keith Whaley, Brandivio, Inc., 1 9494453183, keith.whaley@brandivio.com, https://brandivio.com

View original content to download multimedia:https://www.prweb.com/releases/brandivio-launches-advanced-retail-allocation-platform-for-inventory-excellence-302345595.html

SOURCE Brandivio, Inc.

Continue Reading

Trending